×

 

  • ANNOUNCEMENT
  • Public notice

Public notice

AevisBio entered into a collaborative research with KRIBB

2019-07-01

In July of 2019, AevisBio and Korea Research Institute of Bioscience & Biotechnology (KRIBB) announced a collaboration to discover, develop, and commercialize therapies for treating disease of aging, including Parkinson’s disease.